Newsletter | August 21, 2019

08.21.19 -- Standard Of Care And The Internet Of Medical Things

Featured Editorial
Standard Of Care And The Internet Of Medical Things
By Joseph Honcz, Precision for Value

During the American College of Cardiology annual meeting in March, researchers from Stanford University, Apple Inc., and other academic centers unveiled the Apple Heart Study, a first-of-its-kind large-scale study involving more than 400,000 members of the general population (iPhone and Apple Watch owners). The goal of the study was to identify users with a potentially lethal irregular heart rhythm called atrial fibrillation (AF).

5 Tactics To Overcome Technology And Innovation Adoption Challenges In Clinical Research
By Dennis Salotti, COO, The Avoca Group

Our global digital population — people around the world that are active internet users — has grown to 4.3 billion as of July 2019, representing roughly 56 percent of the global population. Of this global digital population, almost four billion are accessing the internet using mobile devices, with nontablet mobile devices contributing nearly half of web page views worldwide.

Industry Insights
Developing Immunotherapies For Cell-Based vs. Noncell-Based Therapies
Article | Thermo Fisher Scientific

Both cell-based therapies and noncell-based therapies are developed as immunotherapies and therefore share some similar challenges in development.

Clinical Trial Disclosure Management: Build vs. Buy
White Paper | TrialScope

The big challenge for study sponsors is that clinical trial transparency remains a “volatile” area with continuously evolving requirements and expectations. Most life sciences companies don’t have the time, money, or resources to develop a compliance solution.

Critical Milestones Achieved Ahead Of Schedule In Lung Cancer Study
Case Study | IQVIA Biotech

Learn how IQVIA Biotech helped a biotechnology company reach critical milestones as it prepared to launch an international Phase 3 clinical trial for its investigational ALK inhibitor in patients with non-small cell lung cancer.

Evolution Of Parkinson’s Disease Trial Characteristics: 2005 To 2017
Poster | Syneos Health

A longitudinal analysis of Parkinson’s disease (PD) study characteristics provides a deeper understanding of clinical trials dynamics and demonstrates how research paradigms have been changing across the years.

Lessons Learned From The Clinical Trial Trenches: How To Use Patient Engagement Technology Successfully
Webinar | Signant Health, formerly CRF Bracket

The promises of patient engagement technologies are big, but can they be kept? In this webinar experts share the most common questions asked by study teams and discuss how to address them.

Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.

Connect With Clinical Leader: